LifeStance Health Group, Inc. LFST
$12.49
-$0.12-0.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 435.35M | 403.48M | 382.20M | 363.81M | 345.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 435.35M | 403.48M | 382.20M | 363.81M | 345.31M |
| Cost of Revenue | 282.31M | 267.54M | 255.90M | 247.23M | 236.88M |
| Gross Profit | 153.04M | 135.93M | 126.30M | 116.58M | 108.43M |
| SG&A Expenses | 107.23M | 100.24M | 94.74M | 95.69M | 97.38M |
| Depreciation & Amortization | 14.25M | 13.32M | 13.43M | 13.56M | 14.01M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 403.79M | 381.11M | 364.08M | 356.48M | 348.26M |
| Operating Income | 31.56M | 22.37M | 18.12M | 7.33M | -2.95M |
| Income Before Tax | 27.46M | 19.76M | 15.20M | 4.57M | -5.94M |
| Income Tax Expenses | 3.85M | 5.52M | 3.54M | 3.50M | -2.15M |
| Earnings from Continuing Operations | 23.61M | 14.24M | 11.67M | 1.08M | -3.79M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.61M | 14.24M | 11.67M | 1.08M | -3.79M |
| EBIT | 31.56M | 22.37M | 18.12M | 7.33M | -2.95M |
| EBITDA | 45.81M | 35.69M | 31.55M | 20.89M | 11.06M |
| EPS Basic | 0.06 | 0.04 | 0.03 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.05 | 0.03 | 0.02 | 0.01 | -0.01 |
| EPS Diluted | 0.06 | 0.04 | 0.03 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.05 | 0.03 | 0.02 | 0.01 | -0.01 |
| Average Basic Shares Outstanding | 383.52M | 387.26M | 387.00M | 386.96M | 386.73M |
| Average Diluted Shares Outstanding | 387.30M | 395.08M | 396.00M | 388.90M | 386.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |